Sorrento Therapeutics News

Sorrento Therapeutics | 8-K: Current report

Nov 8, 2023 05:34

Sorrento Therapeutics | 8-K: Current report

Nov 4, 2023 05:31

Sorrento Therapeutics | 8-K: Current report

Oct 28, 2023 04:15

Sorrento Therapeutics | 8-K: Current report

Oct 6, 2023 05:26

Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(2.6%)

Oct 6, 2023 05:22

Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.

Oct 6, 2023 05:16

Sorrento Therapeutics | 8-K: Current report

Sep 27, 2023 04:54

Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(1.3%)

Sep 27, 2023 04:49

Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.

Sep 26, 2023 04:27

Sorrento Therapeutics | 8-K: Current report

Sep 13, 2023 09:51

Sorrento Therapeutics | 8-K: Current report

Aug 29, 2023 05:25

Sorrento Therapeutics | 8-K: Current report

Aug 21, 2023 23:20

Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(43.3%)

Aug 15, 2023 08:59

Sorrento Therapeutics | 10-Q: Q2 2023 Earnings Report

Aug 12, 2023 08:00

Sorrento Therapeutics | 8-K: Current report

Aug 11, 2023 04:14

Sorrento Therapeutics | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aug 8, 2023 04:15

Sorrento Therapeutics | 8-K: Current report

Aug 1, 2023 18:01

Sorrento Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Jul 19, 2023 05:23

Sorrento Therapeutics | 8-K: Current report

Jul 13, 2023 18:26

Sorrento Therapeutics | 8-K: Current report

Jul 8, 2023 09:49